Merck & Co. CEO Calls Shkreli "A Hedge Fund Guy Masquerading As A Pharma Exec"

He had harsh words for some fellow pharma executives.

Don’t mistake Turing Pharmaceuticals, the drug company that raised the price a life-saving treatment by more than 5,000% in August, for the whole of the pharmaceutical industry, said Merck & Co. CEO Kenneth Frazier.

“Turing is not the market,” said Frazier. “The CEO spooled up manufacturing in a case where other people left the market.

Back to news